Literature DB >> 16251835

Neurological and neuropsychiatric syndromes associated with liver disease.

Karin Weissenborn1, Martin Bokemeyer, Jochen Krause, Jochen Ennen, Björn Ahl.   

Abstract

The clinical presentation of acute liver failure and hepatic encephalopathy (HE) in patients with cirrhosis differs significantly. The most serious neurological complication of acute liver failure is the development of devastating brain oedema. Therefore, intracranial pressure monitoring is urgently needed in these patients. Brain oedema is amplified by hypoglycemia, hypoxia and seizures, which are also frequent complications of acute liver failure. Therefore, these parameters must also be monitored. In contrast to acute liver failure in which cerebral dysfunction progresses rapidly, cognitive decline may be clinically undetectable for a long time in cirrhotic patients, until clinically overt symptoms such as psychomotor slowing, disorientation, confusion, extrapyramidal and cerebellar symptoms or a decrease in consciousness occur. Clinically, overt HE is preceded by minimal alterations of cerebral function that can only be detected by neuropsychological or neurophysiological measures, but which nevertheless interfere with the patient's daily living. Rapidly progressing spastic paraparesis (hepatic myelopathy) is a rare complication of cirrhosis. In contrast to HE, it does not respond to blood ammonia lowering therapies but must be considered as an indication for urgent liver transplantation. Cognitive dysfunction has recently been detected in hepatitis C virus (HCV)-infected patients with normal liver function. The patients presented with severe fatigue, cognitive dysfunction and mood disorders. Alterations in brain metabolites, as detected by magnetic resonance spectroscopy, indicated central nervous system alteration in these patients. In contrast to patients with HE, HCV-infected patients did not show motor symptoms or deficits in visual perception, but considerable deficits in attention and concentration ability.

Entities:  

Mesh:

Year:  2005        PMID: 16251835     DOI: 10.1097/01.aids.0000192076.03443.6d

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  24 in total

1.  Bacterial meningitis complicating the course of liver cirrhosis.

Authors:  Pasquale Pagliano; Giovanni Boccia; Francesco De Caro; Silvano Esposito
Journal:  Infection       Date:  2017-06-14       Impact factor: 3.553

Review 2.  Encephalopathy in Wilson disease: copper toxicity or liver failure?

Authors:  Peter Ferenci; Tomasz Litwin; Joanna Seniow; Anna Czlonkowska
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

3.  Endozepine-4 levels are increased in hepatic coma.

Authors:  Giulia Malaguarnera; Marco Vacante; Filippo Drago; Gaetano Bertino; Massimo Motta; Maria Giordano; Michele Malaguarnera
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

4.  Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.

Authors:  Carmina Montoliu; Blanca Piedrafita; Miguel A Serra; Juan A del Olmo; Antonio Ferrandez; José M Rodrigo; Vicente Felipo
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

5.  Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.

Authors:  Sérgio Monteiro de Almeida; Ana Paula de Pereira; Maria Lucia Alves Pedroso; Clea E Ribeiro; Indianara Rotta; Bin Tang; Anya Umlauf; Donald Franklin; Rowan G Saloner; Maria Geny Ribas Batista; Scott Letendre; Robert K Heaton; Ronald J Ellis; Mariana Cherner
Journal:  J Neurovirol       Date:  2018-03-07       Impact factor: 2.643

6.  Physiologic dysfunction scores and cognitive function test performance in U.S. adults.

Authors:  Roni W Kobrosly; Christopher L Seplaki; Courtney M Jones; Edwin van Wijngaarden
Journal:  Psychosom Med       Date:  2011-12-07       Impact factor: 4.312

7.  Risk of seizures and status epilepticus in older patients with liver disease.

Authors:  Ayham M Alkhachroum; Clio Rubinos; Benjamin R Kummer; Neal S Parikh; Monica Chen; Abhinaba Chatterjee; Alexandra Reynolds; Alexander E Merkler; Jan Claassen; Hooman Kamel
Journal:  Epilepsia       Date:  2018-06-06       Impact factor: 5.864

Review 8.  Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy.

Authors:  Omar Cauli; Regina Rodrigo; Marta Llansola; Carmina Montoliu; Pilar Monfort; Blanca Piedrafita; Nisrin El Mlili; Jordi Boix; Ana Agustí; Vicente Felipo
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

9.  Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo.

Authors:  Leon M Tai; Kevin P Koster; Jia Luo; Sue H Lee; Yue-Ting Wang; Nicole C Collins; Manel Ben Aissa; Gregory R J Thatcher; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2014-09-12       Impact factor: 5.157

Review 10.  Psychiatric aspects of organ transplantation in critical care.

Authors:  Andrea DiMartini; Catherine Crone; Marian Fireman; Mary Amanda Dew
Journal:  Crit Care Clin       Date:  2008-10       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.